{"DataElement":{"publicId":"5695945","version":"1","preferredName":"Study Site Stop Clinical Study Participation Reason","preferredDefinition":"A coded numeric explanation of what caused a facility that conducts study/protocol activities to cease from taking part in a study.","longName":"5695697v1.0:5695725v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5695697","version":"1","preferredName":"Study Site Stop Clinical Study Participation","preferredDefinition":"A facility in which study/protocol activities are conducted._Put an end to a state or an activity._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._The act of taking part in an activity.","longName":"2867638v1.0:5695695v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2867638","version":"1","preferredName":"Study Site","preferredDefinition":"A facility in which study/protocol activities are conducted.","longName":"C80403","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Site","conceptCode":"C80403","definition":"A facility in which study/protocol activities are conducted.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"694171D2-A7D0-0CA7-E040-BB89AD436B92","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5695695","version":"1","preferredName":"Stop Clinical Study Participation","preferredDefinition":"Put an end to a state or an activity.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:The act of taking part in an activity.","longName":"C65125:C15206:C25608","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stop","conceptCode":"C65125","definition":"Put an end to a state or an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Participation","conceptCode":"C25608","definition":"The act of taking part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D6BAA1-2D5D-4B7F-E053-F662850ACAD0","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"ONEDATA","dateModified":"2017-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2178071","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CC049DE1-E966-5FB4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D6BAA1-2D6E-4B7F-E053-F662850ACAD0","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for Lost to Follow-Up form, 3/3/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5695725","version":"1","preferredName":"Site Stop Study Participation Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"5695725v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"88","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A39324C-A131-57B4-E053-F662850A9803","beginDate":"2017-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-08","modifiedBy":"ONEDATA","dateModified":"2017-03-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Budget Reason","ValueMeaning":{"publicId":"5699509","version":"1","preferredName":"Budget Reason","longName":"5699509","preferredDefinition":"A summary of intended expenditures along with proposals for how to meet them; a sum of money allocated for a particular purpose.: An explanation of the cause of some phenomenon or action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Budget","conceptCode":"C60757","definition":"A summary of intended expenditures along with proposals for how to meet them; a sum of money allocated for a particular purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A39324C-A13F-57B4-E053-F662850A9803","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A39324C-A15A-57B4-E053-F662850A9803","beginDate":"2017-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-08","modifiedBy":"ONEDATA","dateModified":"2017-03-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Study Site Dissolved Negation Conduct Clinical Trials","ValueMeaning":{"publicId":"5699510","version":"1","preferredName":"Study Site Dissolved Negation Conduct Clinical Trials","longName":"5699510","preferredDefinition":"An indication that a study site has closed down and is no longer participating in a study.: An operation in which a term denies or inverts the meaning of another term or construction.: Conduct clinical trials and develop new trial methodologies. Trials should be designed in order to rapidly develop new therapeutic strategies, optimize clinical efficacy and proper use of available modalities, define factors that affect the success of therapeutic strategies (including the role of resistance), and advance our understanding of disease pathogenesis and progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Site Dissolved","conceptCode":"C132259","definition":"An indication that a study site has closed down and is no longer participating in a study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Conduct Clinical Trials","conceptCode":"C15793","definition":"Conduct clinical trials and develop new trial methodologies. Trials should be designed in order to rapidly develop new therapeutic strategies, optimize clinical efficacy and proper use of available modalities, define factors that affect the success of therapeutic strategies (including the role of resistance), and advance our understanding of disease pathogenesis and progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A39324C-A168-57B4-E053-F662850A9803","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A39324C-A183-57B4-E053-F662850A9803","beginDate":"2017-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-08","modifiedBy":"ONEDATA","dateModified":"2017-03-08","deletedIndicator":"No"},{"value":"1","valueDescription":"Institutional Review Board Study Terminated","ValueMeaning":{"publicId":"5695726","version":"1","preferredName":"Institutional Review Board Study Terminated","longName":"5695726","preferredDefinition":"A specially constituted independent review body comprised of medical, scientific and non-scientific members established and designated by an entity to ensure the protection of the rights, safety and well-being of human subjects recruited to participate in biomedical or behavioral research according to the requirements outlined in Title 38, part 16 (same as Title 45, part 46 and Title 21, part 56) of the U.S. Code of Federal Regulations. IRB responsibility include but not limited to the reviewing, approving, and providing continuing review of trial protocol and amendments and of the methods and material(s) to be used in obtaining and documenting informed consent of the trial. Other equivalent committees with the same or similar functions are also considered to be IRBs.: A clinical study status designating the study has been stopped prematurely and will not resume. Subject enrollment stopped. No participants are treated or being followed up.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Institutional Review Board","conceptCode":"C16741","definition":"A specially constituted independent review body comprised of medical, scientific and non-scientific members established and designated by an entity to ensure the protection of the rights, safety and well-being of human subjects recruited to participate in biomedical or behavioral research according to the requirements outlined in Title 38, part 16 (same as Title 45, part 46 and Title 21, part 56) of the U.S. Code of Federal Regulations. IRB responsibility include but not limited to the reviewing, approving, and providing continuing review of trial protocol and amendments and of the methods and material(s) to be used in obtaining and documenting informed consent of the trial. Other equivalent committees with the same or similar functions are also considered to be IRBs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Study Terminated","conceptCode":"C70757","definition":"A clinical study status designating the study has been stopped prematurely and will not resume. Subject enrollment stopped. No participants are treated or being followed up.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D7C2ED-FBB3-3D96-E053-F662850A2757","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"49D7C2ED-FBCE-3D96-E053-F662850A2757","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"ONEDATA","dateModified":"2017-03-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D7C2ED-FB99-3D96-E053-F662850A2757","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for added section on Lost to Follow-Up form. 3/3/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason site stopped participa","type":"Preferred Question Text","description":"Reason site stopped participating","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D82050-89C8-5168-E053-F662850A4D8B","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for additional section in Lost to Follow-Up, 3/3/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}